Press release
Bioresorbable Implants Market to Double, Reaching US$ 14.34 Billion by 2033 at 7.4% CAGR as Orthopedics and Cardiovascular Redefine Healing | DataM Intelligence
Bioresorbable Implants Market
The shift from traditional metallic implants to bioresorbable alternatives reflects a broader transformation toward patient safety, reduced complications, cost efficiency, and natural tissue regeneration. Unlike conventional devices requiring removal, bioresorbable implants from leaders like Stryker Corporation, Johnson & Johnson (DePuy Synthes), Bioretec Ltd, Zimmer Biomet, Smith+Nephew, and Evonik Industries AG gradually degrade, supporting healing in orthopedics and cardiovascular applications. This innovation is not just a material upgrade; it is a paradigm shift in trauma fixation, fracture repair, ACL reconstruction, and bioresorbable stents.
Download Exclusive Sample Report: https://www.datamintelligence.com/download-sample/bioresorbable-implants-market?jd
Browse in-depth TOC on "Bioresorbable Implants Market"
58 - Tables
60 - Figures
185 - Pages
Market Segmentation - Growth Anchors
By Material Type
In 2024, polymer-based implants dominated with 60% of total revenues (US$ 4.2 billion), led by PLLA (Poly L-lactide) for orthopedic fixation due to its strength and predictable degradation. PLGA, PGA, PLA, and Others gain traction in applications needing tuned resorption. Metallic bioresorbables (e.g., magnesium alloys) accounted for around US$ 1.5 billion in 2024 and are emerging rapidly for faster healing and mechanical support.
By Application
Orthopedics generated US$ 3.8 billion in 2024, fueled by sports injuries, trauma, pediatric cases, and fixation devices like screws, pins, and plates. Cardiovascular contributed US$ 2.5 billion, led by bioresorbable vascular scaffolds/stents with lower late thrombosis risk. Others include craniomaxillofacial and soft tissue applications.
By End-User
Hospitals accounted for over 65% of revenues in 2024 (US$ 4.6 billion), central to complex procedures. Ambulatory Surgical Centers (ASCs) valued at US$ 1.8 billion grow rapidly with minimally invasive shifts to outpatient settings.
Regional Insights: United States & Japan
United States
The U.S., valued at US$ 2.8 billion in 2024, leads due to:
-High volume of orthopedic and cardiovascular surgeries (over 1.5 million annually).
-FDA fast-tracking of superior-safety devices.
-Recent update (2025): Johnson & Johnson's DePuy Synthes launched a new line of bioresorbable orthopedic fixation devices, gaining rapid adoption in trauma centers.
Japan
Japan's market, valued at US$ 0.6 billion in 2024, expands rapidly, supported by:
-Aging population driving fracture fixation and cardiovascular needs.
-PMDA approvals of magnesium implants in 2025.
-Collaborations between Stryker, Evonik, and Japanese hospitals for polymer integration.
Request for Customized Sample Report as per Your Business Requirement: https://www.datamintelligence.com/customize/bioresorbable-implants-market?jd
Industry Trends & 2025 Developments
-Metallic Bioresorbable Acceleration: In 2025, magnesium- and zinc-based implants entered late-stage trials and gained approvals for tailored degradation and enhanced strength.
-3D-Printed Customization: U.S. and Japanese hospitals adopted 3D printing for patient-specific bioresorbable implants in 2025.
-M&A Activity: Stryker acquired a European polymer startup in 2025 specializing in next-gen bioresorbable plates.
-Digital & Precision Integration: Surgical navigation combined with implants reduced revision risks in 2025.
Competitive Landscape: Leaders Driving the Future
Stryker Corporation
Stryker generated US$ 1.3 billion in bioresorbable revenues in 2024, leading in trauma fixation and sports medicine.
Johnson & Johnson (DePuy Synthes)
Johnson & Johnson achieved US$ 1.1 billion in 2024, expanding in orthopedic and cardiovascular with 2025 PLLA-based launches.
Bioretec Ltd
Bioretec pioneers magnesium-based implants; in 2025, secured CE mark for RemeOsTM trauma screws and advanced FDA clearances.
Zimmer Biomet & Smith+Nephew
Combined US$ 1.6 billion in 2024, scaling polymer portfolios for sports injuries and pediatrics.
Evonik Industries AG
Evonik supplies key polymers (Resomer® range) powering industry-wide bioresorbable lines.
Other Key Players
CONMED Corporation, Syntellix AG, NuVasive Inc., and KLS Martin Group advance specialized applications.
Buy This Exclusive Report at Just USD 4350 Only: https://www.datamintelligence.com/buy-now-page?report=bioresorbable-implants-market
Strategic Outlook
The Bioresorbable Implants Market is entering its most transformative phase during 2025-2033. Four key forces will define its trajectory:
-Material Innovation - Magnesium, zinc, and hybrid resorbables will set clinical benchmarks.
-Minimally Invasive Growth - ASCs and outpatient shifts will boost adoption.
-Regulatory Acceleration - Faster U.S./Japan approvals will enhance confidence.
-Value-Based Care - Reduced complications and costs will drive large-scale hospital uptake.
Conclusion
The Bioresorbable Implants Market, projected to rise from US$ 7.00 billion in 2024 to US$ 14.34 billion by 2033, is no longer niche-it's the future of surgical implants. With the U.S. leading adoption and Japan excelling in innovation, the sector offers compelling opportunities for hospitals, device makers, and investors.
Contact Us:
DataM Intelligence 4market Research LLP
USA: +1 877-441-4866
Email: Sai.k@datamintelligence.com
Visit Our Website: https://www.datamintelligence.com/
About DataM Intelligence
DataM Intelligence is a renowned provider of market research, delivering deep insights through pricing analysis, market share breakdowns, and competitive intelligence. The company specializes in strategic reports that guide businesses in high-growth sectors such as nutraceuticals and AI-driven health innovations.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Bioresorbable Implants Market to Double, Reaching US$ 14.34 Billion by 2033 at 7.4% CAGR as Orthopedics and Cardiovascular Redefine Healing | DataM Intelligence here
News-ID: 4371194 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
Electrocardiograph (ECG) Market to Reach US$ 15.22 Billion by 2033 at 7.7% CAGR; …
The global electrocardiograph (ECG) market was valued at US$ 7.84 billion in 2024 and is expected to reach US$ 15.22 billion by 2033, growing at a CAGR of 7.7% during the forecast period 2025-2033. Market growth is supported by the rising prevalence of cardiovascular diseases, increasing demand for early diagnosis and continuous cardiac monitoring, and expanding adoption of ECG devices across hospitals, diagnostic centers, and homecare settings. Technological progress, including…
Pipeline Monitoring System Market is set to reach USD 22.2 billion by 2030, Nort …
The Global Pipeline Monitoring System Market reached USD 12.9 billion in 2022 and is expected to reach USD 22.2 billion by 2030, growing with a CAGR of 7.1% during the forecast period 2024-2031. The Global Pipeline Monitoring System Market has witnessed significant growth in recent years, driven by the increasing demand for efficient and safe pipeline operations across various industries.
Get a Free Sample PDF Of This Report (Get Higher Priority…
Japan Genomic Medicine Market to Reach US$ 6.8 Billion by 2032 at 14.9% CAGR; Ka …
The Japan Genomic Medicine market was valued at US$ 1.6 billion in 2024 and is projected to reach US$ 6.8 billion by 2032, growing at a CAGR of 14.9% during the forecast period 2025-2032. Market growth is driven by strong government support for precision medicine, increasing adoption of next-generation sequencing technologies, and expanding use of genomic data in oncology, rare disease diagnosis, and pharmacogenomics. Japan's aging population and rising burden…
Network Forensics Market Set for Explosive Growth to USD 6.81 Billion by 2032, L …
The Global Network Forensics Market reached USD 2.79 billion in 2024 and is expected to reach USD 6.81 billion by 2032, growing at a robust CAGR of 12.01% during the forecast period 2025-2032.
Market growth is driven by escalating cybersecurity threats, rising incidences of advanced persistent threats (APTs) and ransomware attacks, and the increasing complexity of enterprise networks. Advancements in AI-powered threat detection, growing adoption of cloud and hybrid infrastructures, surging…
More Releases for Bioresorbable
Bioresorbable Vascular Scaffold Market A Scaffolding Revolution: The Soaring Bio …
Bioresorbable Vascular Scaffold Market worth $300.21 Mn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Bioresorbable Vascular Scaffold Market- (By Product Type (Enviroximes-eluting Device, Novalis's-eluting Device, Sirolimus-eluting Device. Others), By Disease Type (Coronary Artery Disease, Peripheral Artery Disease), By Material Type (Poly-L-Lactic Acid (PLLA), Tyrosine-derived Polycarbonate, Others), By End-user (Hospital, Ambulatory Surgical Center, Cardiac…
Unlocking Prosperity: Bioresorbable Polymers Market Insights
𝐆𝐫𝐨𝐰𝐭𝐡 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭𝐬, a renowned Market research firm, introduces its latest research report on the 𝐁𝐢𝐨𝐫𝐞𝐬𝐨𝐫𝐛𝐚𝐛𝐥𝐞 𝐏𝐨𝐥𝐲𝐦𝐞𝐫𝐬 𝐌𝐚𝐫𝐤𝐞𝐭, providing a detailed guide for businesses seeking growth progression. This report is meticulously crafted to aid in investment decisions, offering crucial insights and encouraging strategic investment discretion for new entrants aiming for seamless Market penetration.
𝐏𝐃𝐅 𝐒𝐚𝐦𝐩𝐥𝐞 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞 𝐨𝐟 𝐭𝐡𝐞 𝐁𝐢𝐨𝐫𝐞𝐬𝐨𝐫𝐛𝐚𝐛𝐥𝐞 𝐏𝐨𝐥𝐲𝐦𝐞𝐫𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 https://growthmarketreports.com/request-sample/5738
𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐬 𝐨𝐟 𝐁𝐢𝐨𝐫𝐞𝐬𝐨𝐫𝐛𝐚𝐛𝐥𝐞 𝐏𝐨𝐥𝐲𝐦𝐞𝐫𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭:
The global bioresorbable polymers market…
Growing Demand for Bioresorbable Medical Implants to Drive Bioresorbable Polymer …
According to our latest market study, titled "Bioresorbable Polymers Market to 2028- Covid-19 Impact and Global Analysis by Type [Polylactic Acid (PLA), Polyglycolic Acid (PGA), Polydioxanone, Polycaprolactone (PCL), and Others] and Application (Orthopedic Devices, Drug Delivery, and Others),'' The bioresorbable polymers market was valued at US$ 3,260.07 million in 2021 and is projected to reach US$ 6,463.07 million by 2028. It is expected to grow at a CAGR of 10.3%…
Bioresorbable Polymers Market Future Business Status and Prospects Bioresorbable …
(Latest Industry Report 2022) Bioresorbable Polymers Market report provides a basic overview of the industry including definitions and classifications. The market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. The study provides a complex examination of the application, including a detailed cost assessment analysis of the products available in the global market with respect to the profit margins of established…
Bioresorbable Implants Market Future Adoption Overview 2028
Global Bioresorbable Implants Market: Overview
The global bioresorable implants market is gaining traction, owing to the convenience it provides to the healthcare sector in improving the damaged and injured biological structures. Previously, the conventional implants were highly used by orthopedic surgeons for fixing several internal structures. These traditional implants have required a lot of advancement and development over the decades. However, the advanced form of implants which is also known as…
Bioresorbable Implants Market Snapshot by 2017 – 2025
Global Bioresorbable Implants Market: Key Players
Currently, the global bioresorbable implants market is highly competitive owing to the involvement of many established players. Some of the key players in the global bioresorbable implants market are Bioretec, DePuy Synthes, Stryker, Smith & Nephew, Biomet, Medtronic and Nu Vasive.
Conventional implants were used by orthopedic surgeons previously to fix internal fixation for years. These implants have required a lot of development over the decades.…
